אנסטרוזול מדיטק 1 מ"ג

Country: Իսրայել

language: եբրայերեն

source: Ministry of Health

active_ingredient:

ANASTROZOLE 1 MG

MAH:

SAM-ON LTD

ATC_code:

L02BG03

pharmaceutical_form:

FILM COATED TABLETS

administration_route:

PER OS

manufactured_by:

HELM PHARMACEUTICALS GMBH, GERMANY

therapeutic_group:

ANASTROZOLE

therapeutic_indication:

Treatment of advanced breast cancer in post menopausal women. Efficay has not been demonstrated in estrogen receptor negative patients unless they had a previous positive clinical response to tamoxifen. Adjuvant treatment of postmenopausal women with hormone receptor positive early invasive breast cancer. Adjuvant treatment of early breast cancer in hormone receptor positive postmenopausal women who have received 2 to 3 years of adjuvant tamoxifen.

authorization_date:

2011-01-01